(Q34632848)

3 August 2017

1 reference

title

Development and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests (English)

1 reference

3 August 2017

3

Carl E Frasch

1 reference

3 August 2017

Lucia H Lee

1

1 reference

3 August 2017

Chi-Jen Lee

series ordinal

2

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

Critical Reviews in Microbiology

3 August 2017

published in

1 reference

3 August 2017

volume

28

1 reference

3 August 2017

issue

1

1 reference

3 August 2017

page(s)

27-41

1 reference

Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Clinical isolates of Streptococcus pneumoniae that exhibit tolerance of vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Management of infections caused by antibiotic-resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within Groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Characteristics of immune responses to native and protein conjugated pneumococcal polysaccharide type 14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Decline of Childhood Haemophilus influenzae Type b (Hib) Disease in the Hib Vaccine Era

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Feedback inhibition of glutamine synthetase from green pea seeds.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Potential interventions for the prevention of childhood pneumonia: geographic and temporal differences in serotype and serogroup distribution of sterile site pneumococcal isolates from children--implications for vaccine strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Epidemiology of pneumococcal serotypes and conjugate vaccine formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

21 January 2018

Pneumococcal vaccine.

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Development and validation of an NMR-based identity assay for bacterial polysaccharides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Virulence, immunity, and vaccine related to Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Immunization with a plasmid expressing pneumococcal surface protein A (PspA) can elicit protection against fatal infection with Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

21 January 2018

Overview of DNA vaccines

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

21 January 2018

Immunization with DNA.

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Immunologic epitope, gene, and immunity involved in pneumococcal glycoconjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1040-840291046678

10.1080/1040-840291046678

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference